Last updated: 2026-10-06 20:40:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Seer, Inc. (SEER) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $2.19, with a market capitalization of $124.59M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.55 to $2.41. This page covers its latest market performance, valuation, price trends and company information.
$124.59M | |
$2.34 | |
$86.55 | |
$1.46 | |
$2.33 | |
137.53K | |
503.89K | |
-- | |
$2.41 | |
$1.55 | |
-- | |
-- |
Seer, Inc. (SEER) is trading at $2.19 in after-hours trading as of 2026-10-06 19:59:43, down 6.22% ($0.15) from the regular-session close of $2.33.
After-hours trading shows how investors are pricing SEER after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Seer, Inc. (SEER) moved from $1.91 to $2.19, representing a gain of 14.82% ($0.28).
The stock traded between $1.87 and $2.39 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 483.98 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 74.8%
SEER is currently trading at $2.19, placing it 74.8% of the way from its 52-week low of $1.55 to its 52-week high of $2.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 124 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Seer, Inc. (SEER) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.